Valneva reports positive phase-III results for inactivated, adjuvanted COVID-19 vaccine candidate VLA2001 Read more
Sacituzumab Govitecan receives positive CHMP opinion as 2L treatment for adult patients with metastatic triple-negative breast cancer Read more
FDA approves Verzenio as the first and only CDK4/6 inhibitor for certain people with HR+HER2- high-risk early breast cancer Read more
One-shot Sputnik Light vaccine demonstrates 70 per cent efficacy against Delta variant: Gamaleya Center Read more
ZD7442 reduces risk of developing severe COVID-19 or death in Tackle phase-III outpatient treatment trial Read more
IISER Bhopal proposes biochemical link among COVID-19, diabetes and ageing; proposes therapeutic solutions using existing drugs Read more